Skip to main content
. 2026 Aug 31;16(5):164. doi: 10.3390/jox16050164
AO Adverse outcome
AOP Adverse outcome pathway
As Arsenic
BKMR Bayesian kernel machine regression
Cd Cadmium
CI Confidence interval
Cr(VI) Hexavalent chromium
DIO1-3 Iodothyronine deiodinases 1-3
E1-E3 Experimental modifier-evidence categories
fT3 Free triiodothyronine
fT4 Free thyroxine
GPX Glutathione peroxidase
H1-H4 Human modifier-evidence categories
HBM Human biomonitoring
Hg Mercury
HPT axis Hypothalamic–pituitary–thyroid axis
KE Key event
KER Key-event relationship
MeHg Methylmercury
MIE Molecular initiating event
NIS Sodium iodide symporter
Pb Lead
Se Selenium
SPINA-GD Calculated peripheral deiodinase activity
SPINA-GT Calculated thyroid secretory capacity
Sr Strontium
T3 Triiodothyronine
T4 Thyroxine
Tg Thyroglobulin
TH Thyroid hormone
THSD Thyroid hormone system disruption
TPO Thyroid peroxidase
TSH Thyroid-stimulating hormone
UIC Urinary iodine concentration